The U.S. ophthalmic handheld surgical instruments market size is projected to reach USD 953.7 million by 2030, expanding at a CAGR of 3.8% over the forecast period, according to a recent study by Grand View Research, Inc. The growing prevalence of eye diseases and rising awareness for preventive and early disease diagnosis are key factors driving the demand for ophthalmic handheld surgical instruments in the country.
Early disease diagnosis in case of eye disorders can help prevent permanent loss of vision, and hence, growing awareness about preventive treatments and examinations can help create greater opportunities in the market amid the growing prevalence of such diseases.
The increasing prevalence of vision conditions among younger demographics can be attributed to prolonged usage of electronic gadgets, such as laptops, computers, smartphones, and televisions. Long-term exposure to device screens is projected to hamper the user’s ocular health, prompting the need for corrective glasses or contact lenses to avoid permanent damage. In addition, the increased risk of Computer Vision Syndrome (CVS) is anticipated to propel the demand for early disease diagnosis.
The COVID-19 pandemic had a significant negative impact on the ophthalmic handheld surgical instruments market. Factors such as a reduced number of diagnosed diseases due to increased focus on the COVID-19 infected patients and a fall in the number of diagnostic procedures, as a precautionary measure to avoid the spread of the virus, negatively impacted the market. Moreover, the postponement of elective surgeries and reduced number of hospital visits also resulted in a drop in the procedure volume of ophthalmic surgeries during the pandemic.
However, the postponement of cataracts and other elective surgeries created a huge backlog which the healthcare professionals managed to recover from at a rapid pace post the pandemic. Therefore, the ophthalmic handheld surgical instruments market recovered quickly post the pandemic and is expected to grow at a considerable rate over the forecast period as well.
Request a free sample copy or view report summary: U.S. Ophthalmic Handheld Surgical Instruments Market Report
The ophthalmic knives segment dominated the market in 2022 due to the wide availability of these products in different shapes and sizes
The scissors segment is anticipated to witness maximum growth as it is the most found instrument in the surgical kit used for ocular surgeries
The hospital segment held the highest market share in 2022 owing to the presence of skilled staff and a well-equipped emergency care department
The ophthalmic clinics segment is expected to experience maximum growth owing to the factors such as shorter waiting times and low surgery costs
Presence of market players and the availability of technologically advanced products is expected to lead to the continuous growth of the market in the U.S.
Grand View Research has segmented the U.S. ophthalmic handheld surgical instruments market based on product, end-use, and country:
U.S. Ophthalmic Handheld Surgical Instruments Product Outlook (Revenue, USD Billion, 2018 - 2030)
Forceps
Scissors
Chopper
Ophthalmic Knives
Cannula
Others
U.S. Ophthalmic Handheld Surgical Instruments End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Ophthalmic Clinics
Others
U.S. Ophthalmic Handheld Surgical Instruments Country Outlook (Revenue, USD Billion, 2018 - 2030)
U.S.
List of Key Players of the U.S. Ophthalmic Handheld Surgical Instruments Market
BVI
Accutome, Inc.
Medline Industries, Inc.
Haag-Streit Group
Appasamy Associates
Millennium Surgical Corp
Katalyst Surgical
ASICO, LLC.
INKA Surgical Instruments
Surgical Holdings
"The quality of research they have done for us has been excellent..."